Skip Navigation


Annals of Oncology Advance Access originally published online on January 30, 2008
Annals of Oncology 2008 19(6):1180-1186; doi:10.1093/annonc/mdn003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/6/1180    most recent
mdn003v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chen, M.-C.
Right arrow Articles by Lee, K.-D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, M.-C.
Right arrow Articles by Lee, K.-D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

epidemiology

The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma: a population-based study in Taiwan over a 25-year period (1979–2003)

M.-C. Chen1, I.-J. Feng2, C.-H. Lu3,4, C.-C. Chen3,4, J.-T. Lin3,4, S.-H. Huang1 and K.-D. Lee3,4,*

1 Department of Public Health and Biostatistics Consulting Center, School of Medicine, Chang Gung University, Tao-Yuan, Taiwan
2 Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio, USA
3 Department of Hematology and Oncology, Chang Gung Memorial Hospital, Chiayi
4 Department of Nursing, Chang Gung Institute of Technology, Chiayi, Taiwan

* Correspondence to: Dr. K.-D. Lee, Department of Hematology and Oncology, Chang Gung Memorial Hospital, 6 West Sec, Chia-Pu Road, Pu-Tz city, Chiayi 613, Taiwan. Tel: +886-5-3621000 ext 2772; Fax: +886-5-3623781; E-mail: kdlee{at}adm.cgmh.org.tw

Background: Very few reports are available on the incidence and risk of second primary cancers in nasopharyngeal carcinoma (NPC) cases, and most of these are single-institution reviews with relatively small case numbers and short follow-up.

Patients and methods: A population-based study was conducted. We quantified standardized incidence ratios (SIRs) and cumulative incidence of second cancers among 23 639 individuals with initial diagnoses of NPC.

Results: We found a 24% increased risk of second cancers in NPC patients compared with the general population [SIR = 1.24, 95% confidence interval 1.15–1.33]. Elevated SIRs were observed in the following second primary cancers: oral/pharyngeal, salivary gland, sarcoma, skin and leukemia/lymphoma. The cumulative incidence >10 years was 3.26%. The risk was higher in younger patients, especially those <40 years old. After diagnosis of second cancers, the median survival time was 1.7 years.

Conclusions: This is the largest population-based study to date from a high-incidence area. We found that NPC is associated with an increased risk of second malignancies, which had a negative impact on the survival of patients who survived NPC.

Key words: cumulative incidence, nasopharyngeal carcinoma, second primary cancer

Received for publication November 30, 2007. Revision received December 25, 2007. Accepted for publication December 31, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.